Safety and Impact of MiniMed 780G™ in 2- to 6-Year-Old Children
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks
Diabetes Technol. Ther. 2023 Feb 01;25(2)100-107, MA Pulkkinen, TJ Varimo, ET Hakonen, MH Harsunen, ME Hyvönen, JN Janér, SM Kiiveri, HM Laakkonen, SM Laakso, K Wehkalampi, MT Hero, PJ Miettinen, AK TuomaalaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.